It’s not in the San Francisco Bay Area or San Diego. Nor is it in North Carolina or Seattle.
This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
It’s in Cambridge, Massachusetts. Kendall Square, to be specific. According to CNBC, there are 130 life sciences companies within a 2.5-square mile radius, making it the densest concentration of biopharmas in the world.
With the likes of Pfizer, Novartis, Biogen, Momenta Pharmaceuticals, Sanofi, and Ironwood Pharmaceuticals already there, companies continue flocking to this hotbed where intellectuals, universities (e.g., MIT, Harvard), and research institutions abound.
Here’s a closer look: